The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CDK4/6 inhibitors and cardiovascular toxicity: Real-world evidence.
 
Oraianthi Fiste
No Relationships to Disclose
 
Michael Liontos
Employment - Pfizer (I)
Stock and Other Ownership Interests - Pfizer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb/Celgene; Ipsen; Janssen; MSD Oncology; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; GlaxoSmithKline; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Pfizer; Roche
 
Maria Gavriatopoulou
Honoraria - Amgen; Celgene; Janssen; Takeda
Consulting or Advisory Role - Amgen; Karyopharm Therapeutics
Research Funding - Novartis
Travel, Accommodations, Expenses - Genesis Pharma; Janssen; Takeda
 
Constantine Dimitrakakis
No Relationships to Disclose
 
George Evangelou
No Relationships to Disclose
 
Vasiliki Nikolaidou
No Relationships to Disclose
 
Elias A. Kotteas
No Relationships to Disclose
 
Kostas N. Syrigos
Honoraria - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
Travel, Accommodations, Expenses - AstraZeneca
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Sanofi; Takeda
 
Flora Zagouri
No Relationships to Disclose